LAVA Therapeutics NV

NASDAQ:LVTX  
6.91
-0.05 (-0.72%)
Earnings Announcements

Lava Therapeutics Provides Business Update And Reports Third Quarter Financial Results

Published: 11/15/2021 12:19 GMT
LAVA Therapeutics NV (LVTX) - Lava Therapeutics Provides Business Update and Reports Third Quarter Financial Results.
Lava Therapeutics NV - Qtrly Net Loss Was EUR 0.23 per Share.
Revenue is expected to be $1.24 Million
Adjusted EPS is expected to be -$0.39

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.65

More details on our Analysts Page.